A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer

Tianjin Chest Hospital2,653 enrolled

Overview

A study to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases

A multi-centre real-world non-interventional observational study to retrospectively collect the study data on patient demographic/tumor biological characteristics and clinical treatments to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases.

Study Type

OBSERVATIONAL

Enrollment

2,653

Conditions

Non-small Cell Lung Cancer

Interventions

SurgeryPROCEDURE

Surgeries plus dissection of lymph nodes

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with surgeries from 2014 to 2017; * Pathologically diagnosed patients with non-small cell lung cancer; * Age \> 18 years old; * Patients with chest surgeries before hospitalization; * Patients with N2 lymph nodes (+) after surgeries who received lymphadenectomy (Group 10 and 11 lymph nodes); Exclusion Criteria: \- Patients with radiotherapies, chemotherapies and biological therapies for tumors

Locations (9)

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China

China People's Liberation Army Hospital

Beijing, Beijing Municipality, China

Henan Cancer Hospital

Zhengzhou, Henan, China

Tongji Hospital Affiliated to Huaxi Technology University

Outcomes

Primary Outcomes

Difference in overall survival (OS)

OS difference in the subgroups of N2 patients with lymph skip metastases and non-skip metastases

Time frame: 2014 - 2017

Secondary Outcomes

Percentage of N2 patients with lymph skip metastases

Time frame: 2014 - 2017

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.